Open access
Aug 2026
Kdm2a histone demethylase ablation restores anti-tumor immunogenicity in liver cancer.
KDM2A acts as a key epigenetic regulator of mitochondrial function, genomic stability, and the tumor immune microenvironment in liver cancer, and may enhance tumor immunogenicity and improve responses to immunotherapy, representing a promising therapeutic strategy.
L. Gragnani, M. Lulli, Patrizio Caini et al.
· British Journal of Cancer · 0 citations